Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Clinical trial NCT07146113 · SUSPENDED

Trial details

NCT number: NCT07146113
Sponsor: AstraZeneca
Status: SUSPENDED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2025-06-30
Primary completion: 2027-06-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.